EUVIMEDEUVIMED entdecken
Crossref

Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren

Stricker, Helena Marie, Wicki, Andreas

Zurich Open Repository and Archive (University of Zurich) · 28.11.2023

DOI: 10.5167/uzh-239014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zurich Open Repository and Archive (University of Zurich), erschienen am 28.11.2023. Verfasst von Stricker und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of immune checkpoint inhibitors has fundamentally changed the treatment landscape of solid tumors in recent years. Even in advanced stages or in tumors with historically poor prognosis, such as triple-negative breast cancer, progression-free survival, as well as overall survival of affected individuals, have considerably improved. As a result, the side effects and consequences of therapy, their detection, and treatment are becoming an increasingly important part of patient follow-up.

Schlagwörter

immune checkpoint inhibitorslate effectsimmune-related adverse eventstriple-negative breast cancersolid tumorscancer immunotherapypatient follow-up

Zitieren

APA

Stricker, Marie, H., Wicki, & Andreas (2023). Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren. Zurich Open Repository and Archive (University of Zurich). https://doi.org/10.5167/uzh-239014

Vancouver

Stricker, Marie H, Wicki, Andreas. Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren. Zurich Open Repository and Archive (University of Zurich). 2023. doi:10.5167/uzh-239014

BibTeX
@article{Stricker2023,
  author = {Stricker and Marie, Helena and Wicki and Andreas},
  title = {Langzeitnebenwirkungen der Immuncheckpoint-Inhibitoren},
  journal = {Zurich Open Repository and Archive (University of Zurich)},
  year = {2023},
  doi = {10.5167/uzh-239014}
}
Kostenlos starten →